Palatin Technologies (PTN) Operating Leases (2020 - 2026)
Palatin Technologies' (PTN) quarterly Operating Leases came in at $97457.0 in Q1 2026, up 44.92% YoY from $67248.0 in Q1 2025, and down 24.49% on a QoQ basis from $129061.0 in Q4 2025.
Palatin Technologies (PTN) Operating Leases (2020 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 7 years of Operating Leases data on file, last reported at $97457.0 in Q1 2026.
- Quarterly Operating Leases rose 44.92% year-over-year to $97457.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97457.0 (up 44.92% YoY) and the FY2025 annual result came in at $33969.0, down 79.26% from the prior year.
- Operating Leases declined to $97457.0 in Q1 2026, from $129061.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $621660.0 in Q1 2022 to a low of $33969.0 in Q2 2025.
- A 5-year average of $292885.5 and a median of $291355.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2025 — Operating Leases sank 79.26% — and 2026, when it soared 44.92%.
- Tracing PTN's Operating Leases over 5 years: stood at $380161.0 in 2022, then retreated by 5.9% to $357744.0 in 2023, then tumbled by 72.03% to $100071.0 in 2024, then climbed by 28.97% to $129061.0 in 2025, then fell by 24.49% to $97457.0 in 2026.
- The last three Operating Leases figures came in at $97457.0 (Q1 2026), $129061.0 (Q4 2025), and $33969.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Palatin Technologies | 40.86 Mn | 40.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97,457.00 |
| Dec 31, 2025 | 129,061.00 |
| Jun 30, 2025 | 33,969.00 |
| Mar 31, 2025 | 67,248.00 |
| Dec 31, 2024 | 100,071.00 |
| Sep 30, 2024 | 132,447.00 |
| Jun 30, 2024 | 163,782.00 |
| Mar 31, 2024 | 262,220.00 |
| Dec 31, 2023 | 357,744.00 |
| Sep 30, 2023 | 481,046.00 |
| Jun 30, 2023 | 544,323.00 |
| Mar 31, 2023 | 320,490.00 |
| Dec 31, 2022 | 380,161.00 |
| Sep 30, 2022 | 465,091.00 |
| Jun 30, 2022 | 529,398.00 |
| Mar 31, 2022 | 621,660.00 |
| Dec 31, 2021 | 715,893.00 |
| Sep 30, 2021 | 808,840.00 |
| Jun 30, 2021 | 900,520.00 |
| Mar 31, 2021 | 986,175.00 |